Imatinib Mesylate Induces Cisplatin Hypersensitivity in BCR-Abl+ Cells by Differential Modulation of P53 Transcriptional and Proapoptotic Activity
Cancer Research - United States
doi 10.1158/0008-5472.can-09-0548
Full Text
Open PDFAbstract
Available in full text
Date
November 24, 2009
Authors
Publisher
American Association for Cancer Research (AACR)